Complete Filing Data
Pagaya Technologies Ltd. reported Temporary Equity Carrying Amount Attributable To Parent of $30.10 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Pagaya Technologies Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | $81.4M | -$401.4M | -$128.4M | -$302.3M | -$91.2M | $14.5M |
| Revenue * | $1.26B | $1.00B | $772.8M | $685.4M | $445.9M | $91.7M |
| Selling And Marketing Expense | $53.6M | $50.4M | $49.8M | $104.2M | $49.6M | $5.7M |
| Research And Development Expense | $75.2M | $76.6M | $74.4M | $150.9M | $66.2M | $12.3M |
| Other Nonoperating Income Expense | -$80.4M | -$83.6M | -$25.5M | -$24.9M | -$55.8M | -$55.0K |
| Operating Income Loss | $263.8M | $66.8M | -$24.4M | -$251.5M | -$5.8M | $21.3M |
| Net Income Loss Attributable To Noncontrolling Interest | -$10.0M | -$44.3M | -$68.3M | $9.5M | $21.6M | $5.5M |
| Income Tax Expense Benefit | -$19.7M | $24.6M | $15.6M | $16.4M | $7.9M | $1.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $51.6M | -$421.1M | -$181.2M | -$276.4M | -$61.6M | $21.2M |
| General And Administrative Expense | $159.6M | $240.8M | $203.4M | $294.2M | $132.2M | $10.7M |
| Cost Of Goods And Services Sold | $749.2M | $597.7M | $508.9M | $451.1M | $232.3M | $49.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $30.6M | -$458.5M | -$188.7M | -$294.9M | -$69.5M | $19.9M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$14.0M | -$45.1M | -$61.5M | $8.1M | $21.6M | $5.5M |
| Comprehensive Income Net Of Tax | $44.6M | -$413.3M | -$127.3M | -$303.0M | -$91.2M | $14.5M |
| Other Comprehensive Income Loss Net Of Tax | -$40.8M | -$12.8M | $8.0M | -$2.1M | $0.00 | |
| Income Loss From Equity Method Investments | -$8.4M | -$4.6M | $488.0K | $5.8M | -$155.0K | $277.0K |
| Goodwill And Intangible Asset Impairment | $4.9M | $3.2M | $2.5M | $3.2M | $0.00 | $0.00 |
| Net Income Loss Available To Common Stockholders Basic | -$401.4M | -$128.4M | -$314.5M | -$134.3M | $4.9M | |
| Income Loss From Equity Method Investments Including Proprietary Investments | -$8.4M | -$4.6M | $489.0K | $5.8M | -$155.0K | |
| Other Comprehensive Income Loss Before Reclassifications Net Of Tax | -$40.8M | -$12.8M | -$8.5M | -$2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $22.5M | $16.7M | $7.9M | -$67.5M | -$74.8M | -$21.2M | -$21.8M | -$31.3M | -$61.0M |
| Revenue * | $339.9M | $317.7M | $282.7M | $249.3M | $242.6M | $237.0M | $201.4M | $185.7M | $175.3M |
| Selling And Marketing Expense | $14.5M | $19.7M | $9.6M | $11.4M | $13.3M | $10.3M | $11.3M | $14.6M | $14.3M |
| Research And Development Expense | $18.2M | $18.5M | $19.4M | $16.7M | $21.9M | $19.4M | $18.0M | $17.7M | $21.1M |
| Other Nonoperating Income Expense | -$27.4M | -$34.9M | -$47.7M | -$30.3M | -$73.2M | -$34.3M | -$47.3M | -$16.9M | -$67.0M |
| Operating Income Loss | $80.0M | $56.5M | $47.7M | $22.4M | $5.0M | $7.7M | $162.0K | -$10.2M | -$25.0M |
| Net Income Loss Attributable To Noncontrolling Interest | $728.0K | -$92.0K | -$5.4M | -$6.8M | -$7.9M | -$10.4M | -$24.2M | -$842.0K | -$37.7M |
| Income Tax Expense Benefit | -$15.2M | $5.0M | -$2.5M | -$11.5M | $14.5M | $5.0M | -$1.2M | $5.0M | $6.7M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $8.1M | $21.5M | -$48.0K | -$85.8M | -$68.2M | -$26.7M | -$47.1M | -$27.1M | -$92.0M |
| General And Administrative Expense | $36.9M | $40.3M | $46.2M | $57.8M | $64.4M | $63.1M | $53.4M | $53.0M | $51.1M |
| Cost Of Goods And Services Sold | $200.6M | $191.5M | $167.1M | $149.0M | $145.6M | $144.9M | $128.8M | $120.6M | $125.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $10.2M | $10.9M | -$13.3M | -$93.4M | -$128.2M | -$53.2M | -$40.9M | -$25.1M | -$82.8M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$135.0K | -$105.0K | -$5.3M | -$6.6M | -$6.7M | -$7.2M | -$21.1M | $3.0M | -$21.3M |
| Comprehensive Income Net Of Tax | $10.3M | $11.0M | -$8.0M | -$86.9M | -$121.6M | -$45.9M | -$19.7M | -$28.1M | -$61.5M |
| Other Comprehensive Income Loss Net Of Tax | -$13.1M | -$5.7M | -$15.8M | -$19.2M | -$45.6M | -$21.5M | $5.1M | $7.0M | $15.8M |
| Income Loss From Equity Method Investments | -$391.0K | $528.0K | $987.0K | ||||||
| Goodwill And Intangible Asset Impairment | $0.00 | $408.0K | $1.5M | ||||||
| Net Income Loss Available To Common Stockholders Basic | $21.3M | $15.6M | $7.4M | -$67.5M | -$74.8M | -$21.2M | |||
| Income Loss From Equity Method Investments Including Proprietary Investments | -$4.6M | -$2.1M | -$391.0K | -$784.0K | -$443.0K | $528.0K | -$65.0K | -$266.0K | $987.0K |
| Other Comprehensive Income Loss Before Reclassifications Net Of Tax | -$13.1M | -$5.7M | -$15.8M | -$19.2M | -$45.6M | -$21.5M | $5.1M | $7.0M | $15.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $480.0M | $326.5M | $559.7M | $553.5M | $1.3M | $88.1M | $13.4M |
| Temporary Equity Carrying Amount Attributable To Parent | $30.1M | $74.3M | $74.3M | $0.00 | $307.0M | $106.0M | $43.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $288.3M | $226.5M | $222.5M | $337.1M | $204.6M | $5.9M | $4.9M |
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $25.8M | $9.8M | $64.4M | $77.8M | $81.5M | $19.9M | |
| Cash And Cash Equivalents At Carrying Value | $235.3M | $187.9M | $186.5M | $309.8M | $190.8M | $5.1M | |
| Repayments Of Secured Debt | $341.4M | $361.4M | $206.4M | $37.7M | $0.00 | $0.00 | |
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | $64.0M | $20.0M | $105.5M | $151.0M | $74.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $61.8M | $4.0M | -$114.5M | $132.5M | $198.7M | $1.0M | |
| Restricted Cash Noncurrent | $19.2M | $4.7M | $6.8M | $814.0K | |||
| Restricted Cash Current | $16.9M | $22.5M | $7.0M | $0.00 | |||
| Retained Earnings Accumulated Deficit | -$862.7M | -$944.0M | -$542.6M | -$414.2M | -$111.9M | ||
| Property Plant And Equipment Net | $30.2M | $38.0M | $41.6M | $31.7M | $7.6M | ||
| Minority Interest | $75.3M | $115.1M | $106.0M | $211.9M | $176.1M | ||
| Liabilities And Stockholders Equity | $1.55B | $1.29B | $1.21B | $1.05B | $590.3M | ||
| Liabilities | $960.5M | $775.3M | $468.4M | $279.7M | $105.9M | ||
| Equity Method Investments | $13.5M | $21.9M | $26.4M | $25.9M | $14.8M | ||
| Assets | $1.55B | $1.29B | $1.21B | $1.05B | $590.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$48.3M | -$11.5M | $444.0K | -$713.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $30.6M | $36.9M | $55.7M | $61.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $438.3M | $366.8M | $335.5M | $462.3M | $526.0M | $626.8M | $671.9M | $703.1M | $716.4M | |
| Temporary Equity Carrying Amount Attributable To Parent | $30.1M | $74.3M | $74.3M | $74.3M | $74.3M | $74.3M | $74.3M | $74.3M | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $264.8M | $242.0M | $229.6M | $181.0M | $267.9M | $310.0M | $284.2M | $331.4M | $316.8M | |
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $3.6M | $4.0M | $4.4M | $2.6M | $2.8M | $2.5M | $26.8M | $16.7M | $12.2M | |
| Cash And Cash Equivalents At Carrying Value | $218.3M | $183.0M | $186.8M | $147.1M | $233.6M | $274.5M | $252.6M | $304.0M | $289.4M | |
| Repayments Of Secured Debt | $46.9M | $38.0M | $57.4M | |||||||
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | $2.8M | $3.9M | $5.2M | $10.1M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.1M | $87.5M | -$20.3M | |||||||
| Restricted Cash Noncurrent | $35.2M | $24.7M | $20.0M | $16.3M | $16.9M | $18.7M | $5.3M | $4.8M | $4.8M | |
| Restricted Cash Current | $23.8M | $18.1M | $18.6M | $17.6M | $17.5M | $16.9M | $26.3M | $22.5M | $22.5M | |
| Retained Earnings Accumulated Deficit | -$897.0M | -$919.5M | -$936.2M | -$706.1M | -$638.6M | -$563.9M | ||||
| Property Plant And Equipment Net | $32.4M | $34.4M | $36.1M | $39.4M | $40.6M | $42.8M | ||||
| Minority Interest | $97.5M | $101.2M | $105.3M | $80.5M | $89.6M | $99.1M | ||||
| Liabilities And Stockholders Equity | $1.46B | $1.40B | $1.28B | $1.37B | $1.45B | $1.48B | ||||
| Liabilities | $889.4M | $856.8M | $763.3M | $753.8M | $763.2M | $683.0M | ||||
| Equity Method Investments | $14.8M | $19.5M | $21.5M | $25.8M | $26.6M | $26.9M | ||||
| Assets | $1.46B | $1.40B | $1.28B | $1.37B | $1.45B | $1.48B | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$45.3M | -$33.1M | -$27.4M | -$90.4M | -$71.1M | -$24.3M | ||||
| Operating Lease Right Of Use Asset | $32.2M | $33.7M | $35.4M | $34.1M | $51.6M | $53.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $54.1M | $61.5M | $71.1M | $241.7M | $67.8M | $156.0K |
| Proceeds From Minority Shareholders | $0.00 | $64.0M | $20.0M | $105.5M | $151.0M | $74.6M |
| Proceeds From Long Term Lines Of Credit | $0.00 | $59.0M | $130.0M | $42.1M | $0.00 | $0.00 |
| Proceeds From Issuance Of Secured Debt | $356.0M | $265.7M | $338.5M | $139.4M | $37.9M | $0.00 |
| Payments To Minority Shareholders | $25.8M | $9.8M | $43.8M | $77.8M | $81.5M | $19.9M |
| Payments To Acquire Property Plant And Equipment | $13.9M | $17.7M | $20.2M | $22.4M | $6.6M | $1.1M |
| Net Cash Provided By Used In Operating Activities | $238.6M | $47.8M | -$21.7M | -$40.0M | $49.8M | $4.3M |
| Net Cash Provided By Used In Investing Activities | -$309.7M | -$479.9M | -$381.5M | -$265.4M | -$140.7M | -$122.8M |
| Net Cash Provided By Used In Financing Activities | $129.6M | $436.7M | $289.1M | $437.9M | $289.6M | $119.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $28.5M | $6.9M | -$17.8M | $32.4M | $13.4M | $2.5M |
| Increase Decrease In Accounts Payable | $3.4M | $5.7M | -$448.0K | -$9.8M | $11.0M | $427.0K |
| Depreciation Depletion And Amortization | $30.1M | $28.8M | $19.1M | $6.3M | $815.0K | $290.0K |
| Payments To Acquire Equity Method Investments | $0.00 | $175.0K | $0.00 | $5.8M | $23.0M | $0.00 |
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | $0.00 | $0.00 | $74.3M | $0.00 | $172.6M | $64.8M |
| Increase Decrease In Receivables | $24.0M | $20.7M | $46.5M | $27.6M | $19.7M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $9.2M | -$12.9M | $23.2M | $4.7M | -$123.0K | |
| Increase Decrease In Deferred Tax Liabilities Net | -$21.2M | -$5.0M | -$8.6M | $0.00 | $0.00 | |
| Proceeds From Sale Of Equity Method Investments | $0.00 | $31.0K | $0.00 | $453.0K | $8.9M | $350.0K |
| Increase Decrease In Operating Lease Liability | -$6.5M | $522.0K | -$3.7M | -$11.2M | $0.00 | |
| Proceeds From Issuance Of Private Placement | $0.00 | $11.9M | $27.9M | $0.00 | $0.00 | |
| Increase Decrease In Operating Right Of Use Asset | -$6.3M | -$1.1M | -$3.9M | -$7.7M | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.3M | -$586.0K | -$515.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Share Based Compensation | $13.2M | $15.5M | $16.4M |
| Proceeds From Minority Shareholders | $0.00 | $2.8M | $10.1M |
| Proceeds From Long Term Lines Of Credit | $0.00 | $44.0M | $100.0M |
| Proceeds From Issuance Of Secured Debt | $49.2M | $97.4M | $82.0M |
| Payments To Minority Shareholders | $4.4M | $2.5M | $12.2M |
| Payments To Acquire Property Plant And Equipment | $3.8M | $5.1M | $5.5M |
| Net Cash Provided By Used In Operating Activities | $34.4M | $17.7M | -$23.7M |
| Net Cash Provided By Used In Investing Activities | -$26.9M | -$228.1M | -$99.7M |
| Net Cash Provided By Used In Financing Activities | -$3.8M | $298.7M | $103.0M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$11.6M | $8.3M | -$22.6M |
| Increase Decrease In Accounts Payable | $3.0M | $1.9M | $999.0K |
| Depreciation Depletion And Amortization | $7.7M | $6.3M | $3.5M |
| Payments To Acquire Equity Method Investments | |||
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | |||
| Increase Decrease In Receivables | $8.8M | $6.8M | $345.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.7M | $1.9M | -$3.5M |
| Increase Decrease In Deferred Tax Liabilities Net | $2.3M | -$5.0M | $45.0K |
| Proceeds From Sale Of Equity Method Investments | |||
| Increase Decrease In Operating Lease Liability | -$1.4M | -$1.5M | -$3.5M |
| Proceeds From Issuance Of Private Placement | $0.00 | $5.3M | $0.00 |
| Increase Decrease In Operating Right Of Use Asset | -$1.5M | -$1.9M | -$2.2M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$646.0K | -$820.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 2.0M | 5.0M | 5.0M | 0.00 | 33.9M | 26.8M | 240.0M |
| Weighted Average Number Of Shares Outstanding Basic | 78.3M | 70.9M | 60.0M | 38.3M | 16.3M | 191.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 83.1M | 70.9M | 60.0M | 38.3M | 16.3M | 206.9M | |
| Earnings Per Share Diluted | $0.93 | $-5.66 | $-2.14 | $-8.22 | $-8.25 | $0.02 | |
| Earnings Per Share Basic | $0.99 | $-5.66 | $-2.14 | $-8.22 | $-8.25 | $0.03 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 2.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 78.5M | 76.9M | 75.8M | 72.7M | 71.8M | 64.5M | 60.7M | 59.6M | 59.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 91.0M | 79.7M | 77.0M | 72.7M | 71.8M | 64.5M | 60.7M | 59.6M | 59.3M |
| Earnings Per Share Diluted | $0.23 | $0.20 | $0.10 | $-0.93 | $-1.04 | $-0.33 | $-0.36 | $-0.53 | $-1.03 |
| Earnings Per Share Basic | $0.27 | $0.20 | $0.10 | $-0.93 | $-1.04 | $-0.33 | $-0.36 | $-0.53 | $-1.03 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Warrants And Rights Outstanding | $4.7M | $893.0K | $3.2M | $1.4M | $27.5M | $2.5M | $83.0K |
| Interest And Dividend Income Operating | $48.4M | $32.3M | $38.7M | $57.8M | $28.9M | $7.0M | |
| Fair Value Adjustment Of Warrants | $3.8M | -$2.3M | $1.8M | -$11.1M | $53.0M | $489.0K | |
| Costs And Expenses | $1.04B | $965.4M | $836.5M | $1.00B | $480.4M | $77.8M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $57.9M | $68.6M | $78.7M | $250.7M | $68.1M | $156.0K | |
| Stock Issued During Period Value Stock Options Exercised | $5.8M | $2.6M | $4.3M | $1.6M | $346.0K | ||
| Repayments Of Long Term Lines Of Credit | $0.00 | $149.0M | $55.0M | $27.1M | $0.00 | $0.00 | |
| Undistributed Earnings Loss Allocated To Participating Securities Basic | $0.00 | $0.00 | $12.2M | $19.6M | $9.6M | ||
| Stock Issued During Period Shares Stock Options Exercised | 735.0K | 572.0K | 914.9K | 1.4M | 329.1K | 1.8M | |
| Additional Paid In Capital | $1.39B | $1.28B | $1.10B | $968.4M | $113.2M | ||
| Interest Paid Net | $91.8M | $80.3M | $17.8M | $4.3M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Warrants And Rights Outstanding | $7.4M | $2.5M | $2.0M | $2.9M | $1.7M | $1.3M | $5.2M | $3.8M | $1.2M |
| Interest And Dividend Income Operating | $14.9M | $10.7M | $7.7M | $8.7M | $8.2M | $7.7M | $10.4M | $10.2M | $10.4M |
| Fair Value Adjustment Of Warrants | $4.9M | $479.0K | $1.1M | $1.2M | $329.0K | -$1.9M | $1.3M | $2.6M | -$190.0K |
| Costs And Expenses | $270.2M | $269.9M | $242.3M | $234.9M | $245.3M | $237.6M | $211.6M | $205.9M | $211.6M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $14.5M | $19.2M | $14.1M | $13.9M | $20.1M | $17.6M | $23.2M | $22.4M | $17.3M |
| Stock Issued During Period Value Stock Options Exercised | $2.0M | $1.1M | $2.3M | $1.7M | $598.0K | $161.0K | $1.1M | $946.0K | $484.0K |
| Repayments Of Long Term Lines Of Credit | $0.00 | $134.0M | $20.0M | ||||||
| Undistributed Earnings Loss Allocated To Participating Securities Basic | $1.3M | $1.0M | $489.0K | $0.00 | $0.00 | $0.00 | |||
| Stock Issued During Period Shares Stock Options Exercised | 376.6K | 97.3K | |||||||
| Additional Paid In Capital | $1.38B | $1.32B | $1.30B | $1.26B | $1.24B | $1.21B | |||
| Interest Paid Net |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.